Pages

Thursday, February 8, 2018

(no safe theophylline for 20 million yet)Teva faces unexpected delay for its migraine drug candidate even as generics pressures worsen | FiercePharma

Teva faces unexpected delay for its migraine drug candidate even as generics pressures worsen | FiercePharma

No comments: